R. Loch Macdonald
2017
In 2017, R. Loch Macdonald earned a total compensation of $1.3M as Chief Scientific Officer at Edge Therapeutics, a 32% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $153,765 |
---|---|
Option Awards | $724,493 |
Salary | $402,000 |
Other | $10,800 |
Total | $1,291,058 |
Macdonald received $724.5K in option awards, accounting for 56% of the total pay in 2017.
Macdonald also received $153.8K in non-equity incentive plan, $402K in salary and $10.8K in other compensation.
Rankings
In 2017, R. Loch Macdonald's compensation ranked 7,749th out of 14,666 executives tracked by ExecPay. In other words, Macdonald earned more than 47.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,749 | 47th |
Manufacturing | 2,905 | 50th |
Chemicals And Allied Products | 944 | 55th |
Drugs | 731 | 58th |
Pharmaceutical Preparations | 570 | 57th |
Macdonald's colleagues
We found four more compensation records of executives who worked with R. Loch Macdonald at Edge Therapeutics in 2017.